White Papers

  1. Can Your Clinical Supply Chain Pass The Brexit Pressure Test?

    - Clinical trial sponsors and clinical supply vendors must fully consider all attributes of their supply chains to ensure continuity of supply post-Brexit. This whitepaper outlines many questions that sponsors and vendors alike should ask

  2. Precision Oncology Trials: A Look Ahead

    Learn how clinical development technologies and advanced analytics navigate sponsors through the challenges of patient scarcity to transform precision oncology research.

  3. Adapting To The Medical Monitor: Driving Tech Adoption In Clinical Analytics

    The reasons behind the physician monitors’ reluctance, and what technology needs to offer to convince monitors their work can be more efficient — quickly detecting safety signals and speeding time to submission.

  4. Choosing The Right Solution: Improving the Clinical Trial Site Feasibility Process

    What are the things that high-performing clinical research sites do that make sponsors return to them again and again?

  5. Five Essential Considerations for Efficient Clinical Trial Site Contracts and Payments

    Insights on how to avoid startup delays, issues executing the clinical trial, or problems with making payments to sites.

  6. Meeting the Challenge of Appropriate Safety Report Distribution During Clinical Trials

    How to bring efficiency back to the  review process and to ensure that investigators are spending their time where it matters most, with the study participants.

  7. Six Practices Of High Performing Clinical Research Sites

    Six things that high-performing clinical research sites do that make sponsors return to them again and again.

  8. The Role Of Observational Research & Patient Registries In Evidence Generation

    Increasingly central in the course of drug development is the inclusion of observational studies, including registries, which provide insights missing from traditional interventional studies.

  9. Pharmacy Services In A Phase I Clinical Research Unit

    This white paper discusses the role of the pharmacy in a modern day Phase I clinical research unit and its role in understanding the safety and pharmacology of a drug before Phase II can begin.

  10. Factors Driving Patient Adherence To Drug Therapy

    In the first annual Patient Adherence Influence Report, Adheris Health and inVentiv Health Consulting set out to understand the most influential factors driving patient adherence or non-adherence and to answer the question: Will the patient cross the finish line at the retail pharmacy, or will he or she walk away?